Self monitoring of blood glucose levels helps patients with diabetes

Oct 01, 2009

Self-monitoring of blood glucose (SMBG) enables those with diabetes to modify their behavior, adjust their medicine and understand their disease to better manage it, according to a recent study, published by SAGE in The Diabetes Educator. The research looked at "paired testing," a self-monitored testing both before and after specific events, to evaluate whether it could assist the patient in making better health and food choice decisions over time.

In the study, sponsored by Roche Diagnostics through an unrestricted educational grant, healthcare professionals from various medical specialties collaborated to review current research regarding the value and utility of SMBG and formulate professional opinions regarding its use. With the goal of encouraging patients' active involvement in the control of their own disease, instead of just blindly following the edicts of their healthcare providers, researchers found that paired testing can be helpful to:

  • provide immediate feedback regarding the impact of specific eating and exercise actions
  • assess critical nuances of the disease to help the patient make the very best choices
  • target specific meals to identify the impact of food choices on levels
  • detect differences between weekend and weekday schedules and habits
  • learn what does and what does not work in the daily management of diabetes
  • facilitate positive and healthy patient self-care behaviors
"Although the utility of SMBG in non-insulin-treated Type 2 diabetes remains controversial," write the authors in the article, "a recent report from the International Diabetes Federation recommends SMBG use in this population if it is used to educate/motivate individuals and/or monitor and adjust therapy. Healthcare providers must develop strategies to utilize SMBG in ways that address these criteria."

More information: The Diabetes Educator article, "Effective Use of Paired Testing in : Practical Applications in Clinical Practice," written by: Christopher G. Parkin, MS, Deborah Hinnen, ARNP, BC-ADM, CDE, FAAN, R. Keith Campbell, RPh, MBA, FASHP, CDE, Patricia Geil, MS, RD, FADA, CDE, David L. Tetrick, MD, and William H. Polonsky, PhD, CDE will be available free of charge for a limited time at http://tde.sagepub.com/cgi/rapidpdf/0145721709347601v1

Source: SAGE Publications

Explore further: Syria hit by flesh-eating maggot disease

add to favorites email to friend print save as pdf

Related Stories

Genetic tests advertised directly to the consumer

Jul 21, 2009

Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers' response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, ...

Home glucose tests may not help

Jun 28, 2007

A British study shows patient monitoring of glucose levels may not be essential to controlling type 2 diabetes for those not taking insulin.

Recommended for you

Syria hit by flesh-eating maggot disease

14 hours ago

Three cases of myiasis have been reported near Damascus, marking the first appearance of the flesh-eating maggot disease in Syria, UN health experts said Friday.

Sperm can carry Ebola for 82 days: WHO

15 hours ago

Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.